The autoimmunity associated with type 1 diabetes often begins in the first years of life, and the diagnosis of type 2 ...

Millions of Medicare enrollees will gain their first-ever coverage for drugs for weight loss under a temporary pilot program ...

Objective To investigate the association between attention-deficit/hyperactivity disorder (ADHD) and cardiometabolic risk profile at the time of type 2 diabetes (T2D) diagnosis and examine ...

Objectives To quantify out-of-pocket (OOP) costs and catastrophic health expenditure (CHE) among patients hospitalised with ...

Scientists at The Wistar Institute have shown that a single injection of a small, circular piece of genetic instructions can ...

After its bankruptcy sale, Genesis Healthcare executives honed in on the evolution of its management team, investing in ...

Research presented at AANP 2026 details how to transition uninsured and underinsured patients with diabetes to affordable primary care services after hospital discharge.

People with diabetes who have had COVID-19 tend to recover more slowly, experience more long COVID complications, have a ...

The federal government has launched a new program to make GLP-1 weight loss drugs more affordable for older Americans.

Adults with type 2 diabetes who were provided medically tailored healthy meals and lifestyle counseling for 6 months had a ...

A new initiative integrated personal continuous glucose monitor reports into routine primary care visits for diabetes.

Medicare will start the GLP-1 Bridge program July 1. Older adults who qualify for the weight-loss drugs will pay a monthly ...